Aireen

Non-invasive, broadly accessible screening of chronic diseases based on retina scans AI analysis

Aireen provides AI based, non-invasive, pain-less screening of chronic diagnoses based on Eye Retina picture.  Since May 2023 Aireen has been certified as class IIb EU-MDR medical device and is widely used among medical facilities to provide broadly accessible screening of Diabetic retinopathy and Age related macular degeneration. Our current development activities are aimed at cardiovascular and neurodegenerative disease detection.